Discovery of PF-06855800, a SAM competitive PRMT5 inhibitor with potent antitumor activity

被引:4
|
作者
Mcalpine, Indrawan J. [1 ]
Tatlock, John [1 ]
Billitti, Joseph [1 ]
Braganza, John [1 ]
Brooun, Alexei [1 ]
Deng Ya-Li [1 ]
Hirakawa, Brad [1 ]
Jensen-Pergakes, Kristen [1 ]
Kumpf, Robert [1 ]
Liu, Wei [1 ]
Maegley, Karen [1 ]
McTigue, Michele [1 ]
Patman, Ryan [1 ]
Rui, Eugene [1 ]
Scales, Stephanie [1 ]
Spiegel, Noah [1 ]
Tran-Dube, Michelle [1 ]
Wang, Fen [1 ]
Wang, Zhenxiong [1 ]
Yamazaki, Shinji [1 ]
Zhang, Tao [1 ]
Wythes, Martin [1 ]
机构
[1] Pfizer Global R&D, San Diego, CA USA
关键词
D O I
10.1158/1538-7445.AM2018-4857
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
4857
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Discovery of SAM competitive, brain-restricted PRMT5 inhibitors with potent antitumor activity
    Tatlock, John
    Billitti, Joseph
    Braganza, John
    Brooun, Alexei
    Deng, Ya-Li
    Hirakawa, Brad
    Jensen-Pergakes, Kristen
    Kumpf, Robert
    Liu, Wei
    Maegley, Karen
    McAlpine, Indrawan
    McTigue, Michele
    Patman, Ryan
    Rui, Eugene
    Scales, Stephanie
    Tran-Dube, Michelle
    Wang, Fen
    Wang, Zhenxiong
    Yamazaki, Shinji
    Zhang, Tao
    Wythes, Martin
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 255
  • [2] Discovery of SAM competitive and non-nucleoside derivative PRMT5 inhibitors with potent antitumor activity
    Yang, Xiaozhi
    Zhou, Wei
    Li, Chenglong
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 257
  • [3] SAM competitive PRMT5 inhibitor PF06939999 demonstrates antitumor activity in splicing dysregulated NSCLC with decreased liability of drug resistance.
    Jensen-Pergakes, Kristen
    Tatlock, John
    Maegley, Karen
    McAlpine, Indrawan
    McTigue, Michele
    Xie, Tao
    Dillon, Christopher
    Wang, Yuli
    Yamazaki, Shinji
    Spiegel, Noah
    Shi, Manli
    Nemeth, Amy
    Miller, Natalie
    Hendrickson, Eleanore
    Lam, Hieu
    Sherrill, John
    Liu, Wei
    Deng, Ya-Li
    Chung, Chi-Yeh
    McMillan, Elizabeth A.
    Palde, Prakash
    Brooun, Alexei
    Braganza, John
    Kephart, Susan E.
    Kumpf, Robert
    Patman, Ryan
    Rui, Eugene
    Scales, Stephanie
    Tran-Dube, Michelle
    Wang, Fen
    Wythes, Martin
    Paul, Thomas
    [J]. CANCER RESEARCH, 2021, 81 (13)
  • [4] SAM-Competitive PRMT5 Inhibitor PF-06939999 Demonstrates Antitumor Activity in Splicing Dysregulated NSCLC with Decreased Liability of Drug Resistance
    Jensen-Pergakes, Kristen
    Tatlock, John
    Maegley, Karen A.
    McAlpine, Indrawan J.
    McTigue, Michele
    Xie, Tao
    Dillon, Christopher P.
    Wang, Yuli
    Yamazaki, Shinji
    Spiegel, Noah
    Shi, Manli
    Nemeth, Amy
    Miller, Natalie
    Hendrickson, Eleanore
    Hieu Lam
    Sherrill, John
    Chung, Chi-Yeh
    McMillan, Elizabeth A.
    Bryant, Shannon Karlicek
    Palde, Prakash
    Braganza, John
    Brooun, Alexei
    Deng, Ya-Li
    Goshtasbi, Vesta
    Kephart, Susan E.
    Kumpf, Robert A.
    Liu, Wei
    Patman, Ryan L.
    Rui, Eugene
    Scales, Stephanie
    Tran-Dube, Michelle
    Wang, Fen
    Wythes, Martin
    Paul, Thomas A.
    [J]. MOLECULAR CANCER THERAPEUTICS, 2022, 21 (01) : 3 - 15
  • [5] The discovery and preclinical characterization of the SAM-competitive PRMT5 inhibitor UCT-000445
    McDermott, Martina S.
    O'Brien, Neil A.
    O'Boyle, Brendan
    Bartberger, Michael
    Loson, Oliver C.
    Chau, Kevin
    Schwab, Ella
    Hong, Jenny
    Zhou, Jiaying
    Hu, Chuhong
    Luo, Tong
    Ayala, Raul
    Glasby, John
    Stoltz, Brian M.
    Slamon, Dennis J.
    [J]. CANCER RESEARCH, 2023, 83 (07)
  • [6] LLY-283, a Potent and Selective Inhibitor of Arginine Methyltransferase 5, PRMT5, with Antitumor Activity
    Bonday, Zahid Q.
    Cortez, Guillermo S.
    Grogan, Michael J.
    Antonysamy, Stephen
    Weichert, Ken
    Bocchinfuso, Wayne P.
    Li, Fengling
    Kennedy, Steven
    Li, Binghui
    Mader, Mary M.
    Arrowsmith, Cheryl H.
    Brown, Peter J.
    Eram, Mohammad S.
    Szewczyk, Magdalena M.
    Barsyte-Lovejoy, Dalia
    Vedadi, Masoud
    Guccione, Ernesto
    Campbell, Robert M.
    [J]. ACS MEDICINAL CHEMISTRY LETTERS, 2018, 9 (07): : 612 - 617
  • [7] Discovery and Pharmacological Characterization of JNJ-64619178, a Novel Small-Molecule Inhibitor of PRMT5 with Potent Antitumor Activity
    Brehmer, Dirk
    Beke, Lijs
    Wu, Tongfei
    Millar, Hillary J.
    Moy, Christopher
    Sun, Weimei
    Mannens, Geert
    Pande, Vineet
    Boeckx, An
    van Heerde, Erika
    Nys, Thomas
    Gustin, Emmanuel M.
    Verbist, Bie
    Zhou, Longen
    Fan, Yue
    Bhargava, Vipul
    Safabakhsh, Pegah
    Vinken, Petra
    Verhulst, Tinne
    Gilbert, Angelique
    Rai, Sumit
    Graubert, Timothy A.
    Pastore, Friederike
    Fiore, Danilo
    Gu, Junchen
    Johnson, Amy
    Philippar, Ulrike
    Morschhauser, Barbara
    Walker, David
    De Lange, Desiree
    Keersmaekers, Vikki
    Viellevoye, Marcel
    Diels, Gaston
    Schepens, Wim
    Thuring, Jan Willem
    Meerpoel, Lieven
    Packman, Kathryn
    Lorenzi, Matthew V.
    Laquerre, Sylvie
    [J]. MOLECULAR CANCER THERAPEUTICS, 2021, 20 (12) : 2317 - 2328
  • [8] AGX323-A SAM-competitive, orally available inhibitor of protein arginine methyltransferase 5 (PRMT5) with potent cellular antiproliferative and in vivo antitumor activity against selected solid cancer types.
    Lee, Francis Y. F.
    Wu, Wen-Lian
    Yang, Zhiqiang
    Tan, John
    [J]. CANCER RESEARCH, 2021, 81 (13)
  • [9] A novel MTA non-competitive PRMT5 inhibitor.
    Malik, Rohit
    Park, Peter K.
    Barbieri, Christopher M.
    Blat, Yuval
    Sheriff, Steven
    Weigelt, Carolyn A.
    Kopcho, Lisa M.
    Celiktas, Muge
    Ruzanov, Max
    Naglich, Joseph G.
    Price, Jennifer L.
    Harner, Mary
    Omalley, Kevin M.
    Deng, Jingjing
    Schmitz, William
    Li, Guo
    Ruan, Zheming
    Qin, Lan-ying
    Duke, Gerald J.
    Rodrigo, Iyoncy
    Witmer, Mark R.
    Harden, David G.
    Demes, Shilpa
    Arey, Brian J.
    Soars, Matt
    Fink, Brian E.
    Gavai, Ashvinikumar V.
    Vite, Gregory D.
    Voliva, Charles F.
    [J]. CANCER RESEARCH, 2021, 81 (13)
  • [10] A novel PRMT5 inhibitor with potent in vitro and in vivo activity in preclinical lung cancer models
    Brehmer, Dirk
    Wu, Tongfei
    Mannens, Geert
    Beke, Lijs
    Vinken, Petra
    Gaffney, Dana
    Sun, Weimei
    Pande, Vineet
    Thuring, Jan-Willem
    Millar, Hillary
    Poggesi, Italo
    Somers, Ivan
    Boeckx, An
    Parade, Marc
    van Heerde, Erika
    Nys, Thomas
    Yanovich, Carol
    Herkert, Barbara
    Verhulst, Tinne
    Du Jardin, Marc
    Meerpoel, Lieven
    Moy, Christopher
    Diels, Gaston
    Viellevoye, Marcel
    Schepens, Wim
    Poncelet, Alain
    Linders, Joannes T.
    Lawson, Edward C.
    Edwards, James P.
    Chetty, Dushen
    Laquerre, Sylvie
    Lorenzi, Matthew V.
    [J]. CANCER RESEARCH, 2017, 77